ERBB2 and breast carcinoma: Breast cancer is the most prevalent malignant tumor in women [1], with its classification rooted in the expression levels of key molecular biomarkers: estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2) [2].